UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 146

Sortiert nach

Comparison of chronic graft-versus-host disease after transplantation of peripheral blood stem cells versus bone marrow in allogeneic recipients: long-term follow-up of a randomized trial

Blood, 2002-07, Vol.100 (2), p.415-419

2002

Volltextzugriff (PDF)

Reduced intensity allogeneic hematopoietic stem cell transplantation for MDS using tacrolimus/sirolimus-based GVHD prophylaxis

Leukemia research, 2012-09, Vol.36 (9), p.1152-1156

2012

Volltextzugriff (PDF)

Use of Fluid-Ventilated, Gas-Permeable Scleral Lens for Management of Severe Keratoconjunctivitis Sicca Secondary to Chronic Graft-versus-Host Disease

Biology of blood and marrow transplantation, 2007-09, Vol.13 (9), p.1016-1021

2007

Volltextzugriff (PDF)

Thrombotic Microangiopathy Associated with Sirolimus Level after Allogeneic Hematopoietic Cell Transplantation with Tacrolimus/Sirolimus-Based Graft-versus-Host Disease Prophylaxis

Biology of blood and marrow transplantation, 2013-02, Vol.19 (2), p.298-304

2013

Volltextzugriff (PDF)

Cyclosporine, Methotrexate, and Prednisone Compared with Cyclosporine and Prednisone for Prophylaxis of Acute Graft-versus-Host Disease

The New England journal of medicine, 1993-10, Vol.329 (17), p.1225-1230

1993

Volltextzugriff (PDF)

Outcome of Patients with Recurrent or Refractory Lymphoma Undegoing Myeloablative Allogeneic HCT Using BEAM Conditioning with Tacrolimus/Sirolimus Based Gvhd Prophylaxis

Biology of blood and marrow transplantation, 2016-03, Vol.22 (3), p.S227-S227

2016

Volltextzugriff (PDF)

Myositis associated with graft-versus-host disease

Current opinion in rheumatology, 1997-11, Vol.9 (6), p.513-519

1997

Volltextzugriff (PDF)

Sclerodermatous Chronic Gvhd in Patients Receiving Tyrosine Kinase Inhibitors after Allogeneic Hematopoeitic Stem Cell Transplant

Biology of blood and marrow transplantation, 2014-02, Vol.20 (2), p.S280-S280

2014

Volltextzugriff (PDF)

Sequential Bortezomib, Dexamethasone, and Thalidomide Maintenance Therapy after Single Autologous Peripheral Stem Cell Transplantation in Patients with Multiple Myeloma

Biology of blood and marrow transplantation, 2012-03, Vol.18 (3), p.486-492

2012

Volltextzugriff (PDF)

NK Cell Recovery and Costimulatory Molecule Profiles After Autologous Hematopoietic Cell Transplantation (HCT) in Multiple Myeloma (MM) Patients

Biology of blood and marrow transplantation, 2013-02, Vol.19 (2), p.S203-S204

2013

Volltextzugriff (PDF)

A phase II study of sirolimus, tacrolimus, and rabbit anti-thymocyte globulin as graft-versus-host prophylaxis after unrelated-donor peripheral blood stem cell transplant

Bone marrow transplantation (Basingstoke), 2012-09, Vol.48 (2), p.278-283

2012

Volltextzugriff (PDF)

Phase-2 trial of an intensified conditioning regimen for allogeneic hematopoietic cell transplant for poor-risk leukemia

Bone marrow transplantation (Basingstoke), 2011-09, Vol.46 (9), p.1256-1262

2011

Volltextzugriff (PDF)

Thalidomide as Salvage Therapy for Chronic Graft-Versus-Host Disease

Blood, 1995-11, Vol.86 (9), p.3604-3609

1995

Volltextzugriff (PDF)

Reduced intensity allogeneic hematopoietic stem cell transplantion for MDS using tacrolimus/sirolimus-based GVHD prophylaxis

Leukemia research, 2012-06, Vol.36 (9), p.1152-1156

2012

Volltextzugriff (PDF)

A Pilot Phase II Trial of Combining Extracorporeal Photopheresis (ECP) and Low Dose IL-2 for Treatment of Sclerodermatous Steroid Refractory Chronic Graft-Versus-Host Disease (cGvHD)

Biology of blood and marrow transplantation, 2019-03, Vol.25 (3), p.S225-S226

2019

Volltextzugriff (PDF)

Analysis of Predictive Power of Prednisone Dose at 3 Months of Treatment on CGVHD Prognosis

Blood, 2007-11, Vol.110 (11), p.1975-1975

2007

Volltextzugriff (PDF)

High-dose therapy followed by autologous peripheral-blood stem-cell transplantation for patients with Hodgkin's disease and non-Hodgkin's lymphoma using unprimed and granulocyte colony-stimulating factor-mobilized peripheral-blood stem cells

Journal of clinical oncology, 1994-10, Vol.12 (10), p.2176-2186

1994

Volltextzugriff (PDF)

Reduced Intensity (RI) Allogeneic Hematopoietic Cell Transplantation (HCT) Improves Outcomes for Older (≥ 60 Yrs) Patients (Pts) with Acute Myeloid Leukemia (AML)

Blood, 2007-11, Vol.110 (11), p.1089-1089

2007

Volltextzugriff (PDF)

Allogeneic Transplant with Standard Conditioning, Reduced Intensity, or Non-Myeloablative Conditioning Regimen for Multiple Myeloma (MM)

Blood, 2005-11, Vol.106 (11), p.5427-5427

2005

Volltextzugriff (PDF)

Busulfan/cyclophosphamide as conditioning regimen for allogeneic bone marrow transplantation for myelodysplasia

Journal of clinical oncology, 1995-12, Vol.13 (12), p.2973-2979

1995

Volltextzugriff (PDF)

Fractionated total body irradiation and high-dose etoposide as a preparatory regimen for bone marrow transplantation for 99 patients with acute leukemia in first complete remission

Blood, 1993-11, Vol.82 (9), p.2920-2928

1993

Volltextzugriff (PDF)

Allogeneic Bone Marrow Transplantation for High-Risk Acute Lymphoblastic Leukemia During First Complete Remission

Blood, 1991-10, Vol.78 (8), p.1923-1927

1991

Volltextzugriff (PDF)

Thrombotic microangiopathy associated with sirolimus levels following allogeneic hematopoietic cell transplantation with tacrolimus/sirolimus-based GVHD prophylaxis

Biology of blood and marrow transplantation, 2012-10, Vol.19 (2), p.298-304

2012

Volltextzugriff (PDF)

1 – 25 von 146

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(116)
Mit Volltextzugriff
(134)

Publikationsform

Artikel
(145)
Bücher
(1)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Comparison of chronic graft-versus-host disease after transplantation of peripheral blood stem cells versus bone marrow in allogeneic recipients: long-term follow-up of a randomized trial

Reduced intensity allogeneic hematopoietic stem cell transplantation for MDS using tacrolimus/sirolimus-based GVHD prophylaxis

Use of Fluid-Ventilated, Gas-Permeable Scleral Lens for Management of Severe Keratoconjunctivitis Sicca Secondary to Chronic Graft-versus-Host Disease

Thrombotic Microangiopathy Associated with Sirolimus Level after Allogeneic Hematopoietic Cell Transplantation with Tacrolimus/Sirolimus-Based Graft-versus-Host Disease Prophylaxis

Cyclosporine, Methotrexate, and Prednisone Compared with Cyclosporine and Prednisone for Prophylaxis of Acute Graft-versus-Host Disease

Outcome of Patients with Recurrent or Refractory Lymphoma Undegoing Myeloablative Allogeneic HCT Using BEAM Conditioning with Tacrolimus/Sirolimus Based Gvhd Prophylaxis

Myositis associated with graft-versus-host disease

Sclerodermatous Chronic Gvhd in Patients Receiving Tyrosine Kinase Inhibitors after Allogeneic Hematopoeitic Stem Cell Transplant

Sequential Bortezomib, Dexamethasone, and Thalidomide Maintenance Therapy after Single Autologous Peripheral Stem Cell Transplantation in Patients with Multiple Myeloma

NK Cell Recovery and Costimulatory Molecule Profiles After Autologous Hematopoietic Cell Transplantation (HCT) in Multiple Myeloma (MM) Patients

A phase II study of sirolimus, tacrolimus, and rabbit anti-thymocyte globulin as graft-versus-host prophylaxis after unrelated-donor peripheral blood stem cell transplant

Phase-2 trial of an intensified conditioning regimen for allogeneic hematopoietic cell transplant for poor-risk leukemia

Thalidomide as Salvage Therapy for Chronic Graft-Versus-Host Disease

Reduced intensity allogeneic hematopoietic stem cell transplantion for MDS using tacrolimus/sirolimus-based GVHD prophylaxis

High-Dose Chemotherapy With or Without Total Body Irradiation Followed by Autologous Bone Marrow and/or Peripheral Blood Stem Cell Transplantation for Patients With Relapsed and Refractory Hodgkin's Disease: Results in 85 Patients With Analysis of Prognostic Factors

A Pilot Phase II Trial of Combining Extracorporeal Photopheresis (ECP) and Low Dose IL-2 for Treatment of Sclerodermatous Steroid Refractory Chronic Graft-Versus-Host Disease (cGvHD)

Analysis of Predictive Power of Prednisone Dose at 3 Months of Treatment on CGVHD Prognosis

High-dose therapy followed by autologous peripheral-blood stem-cell transplantation for patients with Hodgkin's disease and non-Hodgkin's lymphoma using unprimed and granulocyte colony-stimulating factor-mobilized peripheral-blood stem cells

Reduced Intensity (RI) Allogeneic Hematopoietic Cell Transplantation (HCT) Improves Outcomes for Older (≥ 60 Yrs) Patients (Pts) with Acute Myeloid Leukemia (AML)

Allogeneic Transplant with Standard Conditioning, Reduced Intensity, or Non-Myeloablative Conditioning Regimen for Multiple Myeloma (MM)

Busulfan/cyclophosphamide as conditioning regimen for allogeneic bone marrow transplantation for myelodysplasia

Fractionated total body irradiation and high-dose etoposide as a preparatory regimen for bone marrow transplantation for 99 patients with acute leukemia in first complete remission

Allogeneic Bone Marrow Transplantation for High-Risk Acute Lymphoblastic Leukemia During First Complete Remission

Thrombotic microangiopathy associated with sirolimus levels following allogeneic hematopoietic cell transplantation with tacrolimus/sirolimus-based GVHD prophylaxis

Phase I Trial of Total Marrow and Lymphoid Irradiation Transplant Conditioning in Patients with Relapsed/Refractory Acute Leukemia

Suchergebnisse filtern